カテゴリ： MarketLine, アメリカ, 企業調査

Zoetis Inc.：企業の戦略・SWOT・財務情報

◆英語タイトル：Zoetis Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4449
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：46
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Zoetis Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Zoetis Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Zoetis Inc . (Zoetis) is a global animal health company, engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The company offers its products under the product categories that includes Anti-Infective, Vaccines, Parasiticides, Medicated Feed Additives, Other Pharmaceutical Products, Other Non-Pharmaceuticals and Contract Manufacturing. The company has various manufacturing facilities in countries worldwide; and markets its products to countries across North America, Europe, Africa, Asia, Australia and South America. It is headquartered at Parsippany, New Jersey.

Scope

- Detailed information on Zoetis Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Zoetis Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Zoetis Inc. including a breakdown and examination of key business segments
- Intelligence on Zoetis Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Zoetis Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Zoetis Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Zoetis Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Zoetis Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Zoetis Inc.: Company Overview 9
Zoetis Inc.: Overview and Key Facts 9
Zoetis Inc.: Overview 9
Zoetis Inc.: Key Facts 9
Zoetis Inc.: Key Employees 11
Zoetis Inc.: Key Employee Biographies 13
Zoetis Inc.: Major Products and Services 15
Zoetis Inc.: Company History 17
Zoetis Inc.: Management Statement 20
Zoetis Inc.: Locations and Subsidiaries 24
Zoetis Inc.: Key Competitors 26
Zoetis Inc.: Company Analysis 27
Zoetis Inc.: Business Description 27
Zoetis Inc.: SWOT Analysis 28
Zoetis Inc.: SWOT Overview 28
Zoetis Inc.: Strengths 28
Zoetis Inc.: Weaknesses 29
Zoetis Inc.: Opportunities 29
Zoetis Inc.: Threats 30
Zoetis Inc.: Corporate Financial Deals Activity 32
Zoetis Inc.: Financial Deals Overview 32
Zoetis Inc.: Targets and Partners 34
Zoetis Inc.: Top Deals 2014 – 2018YTD* 35
Zoetis Inc.: Advisors 36
Zoetis Inc.: Top Legal Advisors 36
Zoetis Inc.: Top Financial Advisors 36
Zoetis Inc.: Mergers and Acquisitions 37
Zoetis Inc.: Partnership 38
Zoetis Inc.: Divestments 39
Zoetis Inc.: Recent Developments 40
Zoetis Inc.: News and Events Summary 40
Zoetis Inc.: Business Expansion 41
Zoetis Inc.: Corporate Governance 41
Zoetis Inc.: Financial Deals 42
Zoetis Inc.: Financial Performance 42
Zoetis Inc.: Research & Development 43
Zoetis Inc.: Strategy and Operations 43
Appendix 44
Contact Us 44
Methodology 44
About MarketLine 45

List of Tables
Table 1: Zoetis Inc.: Key Facts
Table 2: Zoetis Inc.: Key Employees
Table 3: Zoetis Inc.: Locations and Subsidiaries
Table 4: Zoetis Inc.: Key Competitors
Table 5: Zoetis Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Zoetis Inc.: M&A Activity by Geography (TTM*)
Table 7: Zoetis Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Zoetis Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Zoetis Inc.: Targets and Partners
Table 10: Zoetis Inc.: Top Deals 2014 - 2018YTD*
Table 11: Zoetis Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Zoetis Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Zoetis Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Zoetis Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Zoetis Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 16: Zoetis Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 17: Zoetis Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 18: Zoetis Inc.: News and Events Summary
Table 19: Zoetis Inc.: Business Expansion
Table 20: Zoetis Inc.: Corporate Governance
Table 21: Zoetis Inc.: Financial Deals
Table 22: Zoetis Inc.: Financial Performance
Table 23: Zoetis Inc.: Research & Development
Table 24: Zoetis Inc.: Strategy and Operations

List of Figures
Figure 1: Zoetis Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Zoetis Inc.: M&A Activity by Geography (TTM*)
Figure 3: Zoetis Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Zoetis Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Zoetis Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Zoetis Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Zoetis Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Zoetis Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 9: Zoetis Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Zoetis Inc.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Synairgen Plc (SNG)：製薬・医療：M&Aディール及び事業提携情報
    Summary Synairgen plc (Synairgen) is a drug discovery and development company, which focuses on the development of novel drugs for the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Its pipeline portfolio includes inhaled interferon beta (IFN-ß/SNG …
  • Unitil Corp (UTL)：企業の財務・戦略的SWOT分析
    Summary Unitil Corp (Unitil) is an interstate electricity and natural gas utility company. The company offers construction, operation and maintenance of gas and electric distribution systems. Unitil offers business operations such as electricity distribution, gas distribution utility operations and …
  • Nishimatsu Construction Co Ltd (1820)：企業の財務・戦略的SWOT分析
    Nishimatsu Construction Co Ltd (1820) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Saniona AB (SANION)：企業の財務・戦略的SWOT分析
    Summary Saniona AB (Saniona) formerly Aniona, is a research and development company that develops drugs for central nervous system diseases, autoimmune diseases, metabolic diseases and pain management. The company’s pipeline products include tesofensine, a triple monoamine reuptake inhibitor, which …
  • Barkers (Northallerton) Limited：企業の戦略的SWOT分析
    Barkers (Northallerton) Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Spineway SAS (ALSPW)：企業の財務・戦略的SWOT分析
    Summary Spineway SAS (Spineway) is a medical device company that manufactures, designs, and commercializes surgical implants and instruments. The company offers products such as thoraco-lumbar, cervical, mini invasive products and other bio materials. Its thoraco-lumbar products include mont blanc d …
  • Select Medical Holdings Corporation：企業の戦略・SWOT・財務情報
    Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Smith & Nephew Plc (SN.)：企業の財務・戦略的SWOT分析
    Smith & Nephew Plc (SN.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CIT Group Inc：企業のM&A・事業提携・投資動向
    CIT Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CIT Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • TOTVS SA：企業の戦略・SWOT・財務分析
    TOTVS SA - Strategy, SWOT and Corporate Finance Report Summary TOTVS SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Nativis Inc：医療機器：M&Aディール及び事業提携情報
    Summary Nativis Inc (Nativis) is a clinical stage bio-electronics company. The company provides portfolio of pipeline candidates which are under development for various therapeutic areas such as recurrent glioblastoma, brain metastisis, pain, rheumatoid arthritis, lung cancer and melanoma, among oth …
  • Futuren (FTRN)-エネルギー分野：企業M&A・提携分析
    Summary Futuren, formerly Theolia SA, is a wind energy producer that prospects, develops, constructs, installs and operates wind power projects. It specializes in designing and building onshore wind plants. Futuren conducts these operations for its own account as well as for third parties. The compa …
  • TrustPower Limited：企業の戦略・SWOT・財務分析
    TrustPower Limited - Strategy, SWOT and Corporate Finance Report Summary TrustPower Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • NNEGC Energoatom：企業の戦略的SWOT分析
    NNEGC Energoatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Technicolor SA：企業の戦略・SWOT・財務情報
    Technicolor SA - Strategy, SWOT and Corporate Finance Report Summary Technicolor SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cosan S.A. Industria e Comercio (CSAN3)-エネルギー分野：企業M&A・提携分析
    Summary Cosan S.A. Industria e Comercio (Cosan), a subsidiary of Cosan Limited, is an integrated bioenergy company. It invests in diversified industries, including agribusiness, fuel and natural gas distribution, and lubricants. The company distributes lubricants, fuel oil, and piped natural gas; an …
  • Alinma Bank：企業の戦略・SWOT・財務分析
    Alinma Bank - Strategy, SWOT and Corporate Finance Report Summary Alinma Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Cipher Pharmaceuticals Inc (CPH)：製薬・医療：M&Aディール及び事業提携情報
    Summary Cipher Pharmaceuticals Inc (Cipher) is a pharmaceutical company that develops skin care solutions. The company provides products such as actikerall, a topical solution indicated for the treatment of hyperkeratotic actinic keratosis; beteflam, a topical patch used for the treatment of mild to …
  • Veristat LLC-製薬・医療分野：企業M&A・提携分析
    Summary Veristat LLC (Veristat), a subsidiary of Veristat Holding Inc is a clinical research organization that conducts clinical trials. The organization offers clinical monitoring, clinical project management, data management, CDISC implementation, biostatistics, medical writing, project management …
  • Chronix Biomedical Inc：医療機器：M&Aディール及び事業提携情報
    Summary Chronix Biomedical Inc (Chronix Biomedical) is a molecular diagnostic company that develops blood tests for monitoring minimal residual disease in cancer patients. The company offers tests such as second opinion tests and delta dot tests. Its second opinion tests include supplementary blood …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆